SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-22-000127
Filing Date
2022-09-06
Accepted
2022-09-06 08:00:29
Documents
19
Period of Report
2022-09-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20220906.htm   iXBRL 8-K 46318
2 EX-99.1 exhibit991-noticeofprend.htm EX-99.1 18047
6 exhibit991-noticeofprend001.jpg GRAPHIC 202794
7 exhibit991-noticeofprend002.jpg GRAPHIC 241695
8 exhibit991-noticeofprend003.jpg GRAPHIC 256321
9 exhibit991-noticeofprend004.jpg GRAPHIC 318032
10 exhibit991-noticeofprend005.jpg GRAPHIC 185666
11 exhibit991-noticeofprend006.jpg GRAPHIC 147904
  Complete submission text file 0001485003-22-000127.txt   2077640

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220906.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220906_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220906_pre.xml EX-101.PRE 13046
13 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220906_htm.xml XML 11810
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 221226888
SIC: 2834 Pharmaceutical Preparations